Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philip E. Hass
Balancing Efficacy and Safety of an Anti-Dll4 Antibody Through Pharmacokinetic Modulation
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Clinical Pharmacokinetics
Pharmacology
Efficacy and Safety of an Intravenous Monoclonal Anti-HBs in Chronic Hepatitis B Patients
Liver International
Hepatology
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients With Advanced and/or Metastatic Cancer
Clinical Pharmacokinetics
Pharmacology
A 52-Week, Open-Label Study Evaluating the Safety and Efficacy of Tabalumab, an Anti-B-Cell-Activating Factor Monoclonal Antibody, for Rheumatoid Arthritis
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Edaravone Attenuates Traumatic Brain Injury Through Anti‑inflammatory and Anti‑oxidative Modulation
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Glycan Modulation and Sulfoengineering of Anti–HIV-1 Monoclonal Antibody PG9 in Plants
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
570 Safety and Efficacy of Bertilimumab, a Human Anti-Eotaxin-1 Monoclonal Antibody, in Bullous Pemphigoid in a Phase 2a Study
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Modulation of the Anti-Tumor Efficacy of Photodynamic Therapy by Nitric Oxide
Cancers
Cancer Research
Oncology
